Empty nose syndrome

Signs and symptoms

The major symptoms of ENS include a sensation of suffocation, nasal dryness, nasal burning, nasal crusting, and an impaired sense of airflow through the nose in patients who have had surgery or any procedure to nasal turbinates. ENS can greatly reduce a patient's quality of life and many patients struggle to complete activities of daily living. While ENS is physical in its origin, many ENS patients also struggle with depression, anxiety, and sleep disturbances. Individuals with ENS may experience all or some of these symptoms.

A limited study of ENS patients found that ENS is associated with hyperventilation syndrome (HVS) in 77.3% of the study population. The study suggests that there could be an epidemiological link between ENS and HVS. The possible link between ENS and HVS could be explained by changes to the respiratory control system. Another study found that laryngopharyngeal reflux disease (LPRD) symptoms and prevalence were significantly higher in ENS patients compared to controls.

ENS patients have higher scores on the Epworth Sleepiness Scale compared to control groups. The severity of ENS symptoms correlated with severity of sleepiness. Sleep apnea is correlated with severity of ENS symptoms and high BMI.

Cause

One possible cause may be changes to the nasal mucous membrane and to the nerve endings in the mucosa resulting from chronic changes to the temperature and humidity of the air flowing inside the nose, caused in turn by removal or reduction of the turbinates. The TRPM8 receptor, responsible for the sensation of nasal openness (patency), is activated by high-speed airflow, which cools the nasal lining through evaporation. This cooling triggers signals to the brain, making breathing feel easier. Nasal passage enlargement alters airflow, reducing turbulence and mucosal cooling which results in reduced sensation of airflow. Studies confirm that without the inferior turbinate, air conditioning in the nose is less effective.

Direct damage to the nerves may be a result of surgical intervention; however, as of 2015, there is no technology that allows the mapping of the sensory nerves within the nose, so it is difficult to determine whether this is causative of ENS. Nerve healing varies, sometimes leading to long-term numbness or altered sensation. Investigators have been unable to identify consistent diagnostic or precipitating features, psychological causes leading to a psychosomatic condition have been proposed.

There seems to be a relation between reduced levels of nasal nitric oxide and depression/anxiety symptoms in ENS patients. Both have been shown to be reversible via implantation surgery.

It has been proposed, that the airflow in ENS is changed so that most of the air flows through the middle meatus, compared to most of the air flowing through the inferior meatus in healthy individuals. This can be corrected via inferior meatus augmentation (IMAP surgery).

Diagnosis

No consensus criteria exist for the diagnosis of ENS and many ENTs will wait a year before diagnosing in hopes the patient accepts the new airflow; it is typically diagnosed by ruling out other conditions, with ENS remaining the likely diagnosis if the signs and symptoms are present. A "cotton test" has been proposed, in which moist cotton is held where a turbinate should be or in various locations in the nasal passages, to see if it provides relief and an airflow pattern that allows for natural breathing; while this has not been validated nor is it widely accepted, it may be useful to identify which people may benefit from surgery.

As of 2015, protocols for using rhinomanometry to diagnose ENS and measure response to surgery were under development, as was a standardized clinical instrument (a well defined and validated questionnaire) to obtain more useful reporting of symptoms.

A validated ENS-specific, 6-item questionnaire called the Empty Nose Syndrome 6-item Questionnaire (ENS6Q) was developed as an adjunct to the standard Sino-Nasal Outcome Test 22 (SNOT-22). The ENS6Q is the first validated, specific, adjunct questionnaire to the SNOT-22. It can more reliably identify patients suspected of ENS. The ENS6Q is gaining usage in studies on ENS.

Classification

Four types have been proposed:

• ENS-IT: Inferior turbinate (IT) was fully or partially resected
• ENS-MT: Middle turbinate (MT) was fully or partially resected
• ENS-both: Both the IT and MT were both at least partially resected
• ENS-type: Patient appears to have adequate turbinate tissue but suffers ENS symptoms due to damage to the mucosal surface of the turbinates.

Prevention

Non-surgical methods (steroid, allergy treatment) are usually attempted for an extended period of time prior to surgical intervention. In order to prevent ENS, it was suggested that unnecessary nasal surgery and surgical treatment to the turbinates and septum may be better avoided. Any proposed nasal surgery may require prior imaging of the nasal passages and an opinion from a surgeon who is familiar with ENS. It is sometimes stated that ENS is only seen after excessive turbinate reduction, but studies have shown that any surgery/procedure involving the nasal turbinates can potentially lead to ENS, for example even unilateral, partial reduction of the inferior turbinate may lead to severe ENS. People planning for surgery to the nose for function or appearance should be made aware of the risk of ENS developing if the body does not accept the new airflow and exchange of gasses.

The Haute Autorité de Sante (HAS) guidelines recommend that rhinoplasty/septoplasty shouldn't be followed immediately by any turbinate surgery. Turbinate surgery should be the last resort if medication fails. If reduced, at least two-thirds of the inferior turbinate must remain intact.

Treatment

Initial treatment is similar to atrophic rhinitis, namely keeping the nasal mucosa moist with saline or oil-based lubricants and treating pain and infection as they arise; adding menthol to lubricants may be helpful in ENS, as may be use of a cool mist humidifier at home but has limited success and many ENT patients seek treatment from the few ENTs who specialize in ENS surgical techniques. For people with anxiety, depression, or who are obsessed with the feeling that they can't breathe, psychiatric or psychological care may be helpful.

In some people, surgery to restore missing or reduced turbinates or various fillers that correct the airflow in the nose may be beneficial. Corrective surgical methods are experimental and limited to a few ENT practitioners worldwide.

The most common surgical approach is creation of a pocket under the mucosa and implanting material. Filler materials include noncellular dermis, a medical-grade porous high-density polyethylene, or silastic. Sometimes cartilage from cows or from another part of the person's body is used. Sometimes hyaluronic acid is injected or tricalcium phosphate is used. Possible complications caused by the surgery are over-correction (causing chronic rhinosinusitis) or under correction. The hyaluronic acid may be completely resorbed after one year, or the implant may come out, but this may not affect the result if enough material remains. 21% of the people undergoing surgery for ENS have zero or only marginal improvement, but the rest report significant relief of their symptoms. Available research may suffer from placebo effect or reporting bias since none of the studies used control groups or blinding.

Stemcell treatments to improve function having been tried lack evidence from large samples and long observation. The University of Modena and Reggio Emilia is attempting to create a neo-turbinate from basal cells of the turbinate.

Outcomes

Data measuring the prevalence of Empty Nose Syndrome (ENS) after turbinate surgery is limited to a few single surgeon studies with variable results. Measuring prevalence is challenging as ENS symptoms may not show up for many years after the surgery and the surgeon may no longer be following the patients. Quantifying prevalence will also depend on a valid, standardized definition.

The lack of a reliable epidemiological study or ICD-10 code makes it difficult to understand the incidence of ENS. Qualitative feedback from ENTs that treat this disease indicate that the incidence is underestimated but the condition is debilitating for those that have it.

Untreated, the condition can cause significant and long term physical and emotional distress in some people; some of the initial presentations on the condition described people who committed suicide. Research on safety and efficacy of existing treatments is limited to a handful of published studies with a small number of participants and self-reported results from specialists treating this condition.

History

As early as 1914, Dr Albert Mason reported cases of "a condition resembling atrophic rhinitis" with "a dryness of the nose and throat" following turbinectomy. Mason called the turbinates "the most important organ in the nose" and claimed they were "slaughtered and removed with discriminate abandon more than any other part of the body, with the possible exception of the prepuce." He recommended that true and compensatory hypertrophy be distinguished and that the removal of septal spurs could treat the latter.

The term "Empty Nose Syndrome" was first used by Eugene Kern and Monika Stenkvist of the Mayo Clinic in 1994. Whether the condition existed or not and whether surgery was a cause, was hotly debated at Nose 2000, a meeting of the International Rhinologic Society that occurs every four years, and continued to be debated thereafter at scientific meetings and in the literature; as an example of how heated the debate became, in a 2002 textbook on nasal reconstruction techniques, two surgeons from University of Utrecht called turbinectomies a "nasal crime".

Society and culture

Many people with ENS symptoms commonly encounter doctors who consider their symptoms to be purely psychological. Recognition among rhinologists has been growing.

People who experience ENS have formed online communities and websites to support one another

References

References

1. (February 2011). "Atrophic rhinosinusitis: progress toward explanation of an unsolved medical mystery". Current Opinion in Allergy & Clinical Immunology.
2. (2015). "Empty nose syndrome". Current Allergy and Asthma Reports.
3. (2022-10-28). "Sleep impairment in patients with empty nose syndrome". Rhinology Journal.
4. (April 2023). "International consensus statement on allergy and rhinology: Allergic rhinitis – 2023". International Forum of Allergy & Rhinology.
5. (November 2019). "Management of Postsurgical Empty Nose Syndrome". Facial Plastic Surgery Clinics of North America.
6. Houser, Steven M.. (2007-09-01). "Surgical Treatment for Empty Nose Syndrome". Archives of Otolaryngology–Head & Neck Surgery.
7. "FFAAIR {{!}} Syndrome du Nez Vide (SNV)".
8. Saafan. "Empty nose syndrome: etiopathogenesis and management".
9. (November 2019). "Management of Postsurgical Empty Nose Syndrome". Facial Plastic Surgery Clinics of North America.
10. Sozansky J, Houser SM. (Jan 2015). "Pathophysiology of empty nose syndrome". Laryngoscope.
11. Leong SC. (Jul 2015). "The clinical efficacy of surgical interventions for empty nose syndrome: A systematic review". Laryngoscope.
12. (2012). "Empty nose syndrome". European Annals of Otorhinolaryngology, Head and Neck Diseases.
13. (2011). "Rhinitis sicca, dry nose and atrophic rhinitis: a review of the literature". European Archives of Oto-Rhino-Laryngology.
14. Payne SC. (2009). "Empty nose syndrome: what are we really talking about?". Otolaryngologic Clinics of North America.
15. (January 2017). "The Empty Nose Syndrome 6-Item Questionnaire (ENS6Q): a validated 6-item questionnaire as a diagnostic aid for empty nose syndrome patients". International Forum of Allergy & Rhinology.
16. (June 2018). "The functional and psychological burden of empty nose syndrome". International Forum of Allergy & Rhinology.
17. (September 2017). "Investigating hyperventilation syndrome in patients suffering from empty nose syndrome". The Laryngoscope.
18. (2024-10-11). "Association between empty nose syndrome and laryngopharyngeal reflux disease: a preliminary cohort study". European Archives of Oto-Rhino-Laryngology.
19. (February 2023). "Sleep impairment in patients with empty nose syndrome". Rhinology.
20. (15 July 2022). "Identifying Obstructive Sleep Apnoea in Patients with Empty Nose Syndrome". Diagnostics.
21. Scheithauer, Marc Oliver. (2011-04-27). "Surgery of the turbinates and "empty nose" syndrome". GMS Current Topics in Otorhinolaryngology - Head and Neck Surgery.
22. (2019-11-01). "Nasal nitric oxide in relation to psychiatric status of patients with empty nose syndrome". Nitric Oxide.
23. (2021-05-01). "Inferior meatus augmentation procedure (IMAP) normalizes nasal airflow patterns in empty nose syndrome patients via computational fluid dynamics (CFD) modeling". International Forum of Allergy & Rhinology.
24. (March 2018). "Sino-Nasal outcome test-22 outcomes after sinus surgery: A systematic review and meta-analysis.". The Laryngoscope.
25. (2017). "The Empty Nose Syndrome 6-item Questionnaire: a validated 6-item questionnaire as a diagnostic aid for empty nose syndrome patients". Int Forum Allergy Rhinol.
26. Houser, Steven M.. (2007-09-01). "Surgical Treatment for Empty Nose Syndrome". Archives of Otolaryngology–Head & Neck Surgery.
27. (2013-06-21). "Bailey's Head and Neck Surgery". Lippincott Williams & Wilkins.
28. "Prévention, diagnostic et prise en charge du syndrome du nez vide".
29. (2001). "Atrophic rhinitis: a review of 242 cases". American Journal of Rhinology.
30. (September 1914). "A plea for the conservation of the inferior turbinate". Atlanta Journal-record of Medicine.
31. Harmon, Tomas. (May 4, 2016). "Medical Mystery: Empty Nose Syndrome".
32. "ENS Tips".
33. "Empty nose syndrome aerodynamics".
34. "Nasal Cripple".